From October 18 to 20, PKU Medicine Overseas Exchange and “Clinical Medicine plus X” Cluster Hiring Publicity was successfully held in Boston. The activity aimed to carry out the strategic plan of “Clinical Medicine plus X”, to present the development theory and idea of PKU Medicine on the international platform, and to introduce overseas high-end talents via cluster hiring.

Zhang Ning meets with Professor William C. Hahn, Vice Dean of Dana-Farber Cancer Institute

　　Zhang Ning meets with Academician Lin Xihong from Harvard T. H. Chan School of Public Health

Zhang Ning meets with Professor Harry W. Orf, Vice President of Harvard University Massachusetts General Hospital, and Professor Thomas J. Brady, Director of Nuclear Medicine and Molecular Imaging Center

      On October 20, the delegation attended the “Publicity of PKU Medicine Development Strategy and Clinical Medicine plus X Cluster Hiring” held by PKU and PKUHSC Office of Discipline Building and co-organized by the Chinese Scientists and Scholars Association at Harvard Medical School. After the meeting, the delegation held in-depth exchanges with local scientific researchers who had the intention of coming back to China, and offered answers to questions of popular concerns such as school-attending, housing, and other benefits. 

Publicity of PKU Medicine Development Strategy and Clinical plus X Cluster Hiring

      This overseas visit successfully presented to the world the strategic planning of PKU Medicine, promoted the forming of collaborative intention between PKUHSC and Harvard Medical School in scientific research, and advocated the talent introduction policies and opportunities at PKUHSC through the publicity of Clinical plus X cluster hiring, which will attract more overseas intelligence resource for the development of PKU Medicine. 

　　Written by: Lang Lang

      Edited by: Liu Xin

      Source: PKUHSC Office of Discipline Building